| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 03/21/2002 | CA2422053A1 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses tehreof |
| 03/21/2002 | CA2421952A1 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
| 03/21/2002 | CA2421303A1 Novel compounds |
| 03/21/2002 | CA2421234A1 Interferon-alpha induced gene |
| 03/21/2002 | CA2420459A1 Novel dermatophagoides nucleic acid molecules, proteins and uses thereof |
| 03/21/2002 | CA2419894A1 Process for high throughput screening of cpg-based immuno-agonist/antagonist |
| 03/21/2002 | CA2357619A1 Clustered creature exterminating method |
| 03/20/2002 | EP1188837A1 Process for preparing N-substituted 4-hydroxypiperidines by enzymatic hydroxylation |
| 03/20/2002 | EP1188836A2 Production method of polyester containing epoxy group in side chain and production method of crosslinked polymer |
| 03/20/2002 | EP1188832A1 A delivery method for the tumor specific apoptosis inducing activity of apoptin |
| 03/20/2002 | EP1188828A1 Reg-binding protein |
| 03/20/2002 | EP1188823A1 Transformed microorganism and process for producing d-aminoacylase |
| 03/20/2002 | EP1188822A1 L-amino acid-producing bacteria and process for producing l-amino acid |
| 03/20/2002 | EP1187931A1 49 human secreted proteins |
| 03/20/2002 | EP1187925A1 Pectate lyase fusion for expression and secretion of polypeptides |
| 03/20/2002 | EP1187924A1 Substrate trapping protein tyrosine phosphatases |
| 03/20/2002 | EP1187922A2 Pesticidal proteins |
| 03/20/2002 | EP1187920A2 Recombinant prion-like genes and proteins and materials and methods comprising same |
| 03/20/2002 | EP1187916A2 Identification and molecular characterisation of proteins, expressed in the tick salivary glands |
| 03/20/2002 | EP1187915A2 Compounds for therapy and diagnosis of lung cancer and methods for their use |
| 03/20/2002 | EP1187908A1 42 human secreted proteins |
| 03/20/2002 | EP1187907A1 Method for the preservation of biologically-active material |
| 03/20/2002 | EP1187849A1 Meth1 and meth2 polynucleotides and polypeptides |
| 03/20/2002 | EP1187843A1 Angiogenic proteins and uses thereof |
| 03/20/2002 | EP1187842A1 Human tumor necrosis factor receptor tr10 |
| 03/20/2002 | EP1187841A1 Method for enhanced protein stabilization and production of cell lines useful for production of such stabilized proteins |
| 03/20/2002 | EP1187630A1 Rapid immunoassay to detect antibodies in saliva to disease-related microorganisms antigens |
| 03/20/2002 | EP0628077B1 Humanised antibodies directed against a33 antigen |
| 03/20/2002 | EP0625043B1 Recombinant multivalent m protein vaccine |
| 03/20/2002 | EP0593501B1 Biocidal proteins |
| 03/20/2002 | CN1341151A Herbicide target gene and methods |
| 03/20/2002 | CN1341148A Nucleic acid molecules encoding alternansucrase |
| 03/20/2002 | CN1341146A Fungal cells with inactivated DNA mismatch repair system |
| 03/20/2002 | CN1341029A Use of an OmpA enterobacteriumprotein associated with the ELAGIGILTV peptide for treating melanomas |
| 03/20/2002 | CN1340628A Improved method for biological production of carotenoid and its used biomaterial |
| 03/20/2002 | CN1340609A Growth-promoting antagonistic bacterium M18 for biologic agricultural chemical and its preparing process |
| 03/20/2002 | CN1340542A Polypeptide-human transcription binding factor gamma subunit (CBF-C) 13.42 and polynucleotide for coding it |
| 03/19/2002 | US6359127 Oligonucleotide for use in treatment of cancer and nervous system disorders |
| 03/19/2002 | US6359116 Compounds |
| 03/19/2002 | US6359115 Human receptor tyrosine kinase, KDR |
| 03/19/2002 | US6358969 3-desmethylrapamycin or derivatives thereof, processes for their preparation and their use as antifungal agents and immunosuppressants |
| 03/19/2002 | US6358923 Preventing and diagnosing blood, genetic, and nervous system disorders associated with decreased genetic expression |
| 03/19/2002 | US6358920 Nonapeptide anticarcinogenic and antimetastasis agents |
| 03/19/2002 | US6358742 Evolving conjugative transfer of DNA by recursive recombination |
| 03/19/2002 | US6358741 Polynucleotide coding propagation regulator; for treating cell proliferative defects |
| 03/19/2002 | US6358727 Nucleotide sequences coding binding protein for use in treatment and prevention of infections |
| 03/19/2002 | US6358720 Serine/theonine protein kinase |
| 03/19/2002 | US6358719 Genes for the biosynthesis of epothilones |
| 03/19/2002 | US6358716 Method for the production of glycerol by recombinant organisms |
| 03/19/2002 | US6358715 Production of ascorbic acid |
| 03/19/2002 | US6358711 Generating polyclonal antibody; immunize animal, isolate animal antibodies, screen isolated antibodies with the polypeptide and detect binding of polyclonal antibody |
| 03/19/2002 | US6358710 Humanized antibodies that bind to the antigen bound by antibody NR-LU-13 |
| 03/19/2002 | US6358708 Nucleotide sequence coding segment of enzymatic polypeptide; for use in treatment and prevention of fungal infections; fungicides |
| 03/19/2002 | US6358707 Polynucleotide sequences coding polypeptide associated with cellular secretion; for use in treatment of diabetes, stroke, atherosclerosis, restenosis, thrombosis, autoimmune disease, psoriasis, arthritis, crohn's, and inflammatory defects |
| 03/19/2002 | US6358706 Nucleotide sequences coding membrane protein; for use in treatment of epilepsy, schizophrenia, depression, sleep, stress, muscle, endocrine, respiratory, fertility, contraceptive, cardiovascular disorders and atherosclerosis |
| 03/19/2002 | US6358704 M protein |
| 03/19/2002 | US6358702 Polynucleotides encoding human Hox C10 |
| 03/19/2002 | US6358701 A dna molecule encoding a protein; screening agonists and antagonsits; to determining channel modulators that may have insecticidal, mitacidal and/or nematocidal activity |
| 03/19/2002 | US6358694 Culturing prostaglandin receptor expressing cells in the presence of a test compound; measure the modulating affects of the compound that interacts with the recombinant receptor and compare the affects with a control host cell |
| 03/19/2002 | US6358521 Fermented milk nutraceuticals |
| 03/19/2002 | CA2008390C Mutants of human antithrombin iii |
| 03/19/2002 | CA1341348C Human tumor necrosis factor |
| 03/14/2002 | WO2002020842A1 System, method and apparatus for transgenic and targeted mutagenesis screening |
| 03/14/2002 | WO2002020830A2 Test systems based on transmembrane receptors from helminths and the use thereof for identifying and characterizing compounds |
| 03/14/2002 | WO2002020815A2 Production of cyclic terpenoids |
| 03/14/2002 | WO2002020814A1 Self-rearranging dna vectors |
| 03/14/2002 | WO2002020813A2 Recombinant endothelial cell growth inhibitors derived from a mammalian plasminogen |
| 03/14/2002 | WO2002020810A1 High efficiency retroviral vector which contains genetically engineered cellular non-coding sequence harboring splicing acceptor |
| 03/14/2002 | WO2002020809A1 A delivery method for the tumor specific apoptosis inducing activity of apoptin |
| 03/14/2002 | WO2002020808A1 Isozymes of lacrimator component synthase and gene encoding the same |
| 03/14/2002 | WO2002020807A1 L-methionine $g(g)-lyase with modified function |
| 03/14/2002 | WO2002020801A2 26199, 33530, 33949, 47148, 50226, and 58764, human transferase family members and uses therefor |
| 03/14/2002 | WO2002020799A2 Nucleotide sequences which code for the luxs gene |
| 03/14/2002 | WO2002020797A2 Genes encoding polypeptides from methylomonas sp. involved exopolysaccharide production |
| 03/14/2002 | WO2002020796A2 Methanotrophic carbon metabolism pathway genes and enzymes |
| 03/14/2002 | WO2002020793A1 Chra of corynebacterium glutamicum |
| 03/14/2002 | WO2002020789A1 Gcn4-derived expression of heterologous coding sequences |
| 03/14/2002 | WO2002020788A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/14/2002 | WO2002020767A2 G-csf analog compositions and methods |
| 03/14/2002 | WO2002020766A2 G-csf analog compositions and methods |
| 03/14/2002 | WO2002020764A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/14/2002 | WO2002020763A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/14/2002 | WO2002020762A2 Tnf receptor-like molecules and uses thereof |
| 03/14/2002 | WO2002020757A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/14/2002 | WO2002020736A2 Proteases |
| 03/14/2002 | WO2002020733A2 Genes involved in isoprenoid compound production |
| 03/14/2002 | WO2002020730A2 Manganese lipoxygenase |
| 03/14/2002 | WO2002020728A2 High growth methanotrophic bacterial strain methylomonas 16a |
| 03/14/2002 | WO2002020727A2 Method for propagating fungi using solid state fermentation |
| 03/14/2002 | WO2002020718A2 Osteoclast-associated receptor |
| 03/14/2002 | WO2002020619A2 HUMAN ANTIBODIES AGAINST PSEUDOMONAS AERUGINOSA LPS DERIVED FROM TRANSGENIC XENOMOUSE$m(3) |
| 03/14/2002 | WO2002020615A2 Antibody and/or chemokine constructs which bind to a chemokine receptor and their use in immunological disorders |
| 03/14/2002 | WO2002020611A1 Recombinant fusion protein for diagnosis of tsutsugamushi disease |
| 03/14/2002 | WO2002020597A2 Human vomeronasal receptor-5 |
| 03/14/2002 | WO2002020569A2 Mammalian genes; related reagents and methods |
| 03/14/2002 | WO2002020565A2 Collections of repeat proteins comprising repeat modules |
| 03/14/2002 | WO2002020563A2 RECEPTOR IN THE EDb FIBRONECTIN DOMAIN |
| 03/14/2002 | WO2002020562A2 Family member of inhibitor of apoptosis proteins |
| 03/14/2002 | WO2002020560A1 Novel human cancer/testis antigen and gene thereof |
| 03/14/2002 | WO2002020495A2 Inhibitors of glycogen synthase kinase 3 |